topic: Access to Medicines
Proposed shake-up to drug pricing framework risks middle-income countries paying more
MSF Responds to EMA approval of new tuberculosis drug delamanid
Gilead attempt to secure patent on hepatitis C drug opposed in India
MSF Responds to EMA approval of new tuberculosis drug delamanid
Global Vaccine Community Must Make Major Changes to Reach More Children
US Pressure on India Threatens Access to Medicines
MSF Urges Countries Not to Trade Away Health as Trans-Pacific Trade Pact Negotiations Intensify
Trans-Pacific Trade Agreement Could Block Patient Access to Affordable Generic Medicines
India’s Access to Medicines Policies Under Attack